This course covers common retinal conditions in optometry, including AMD, diabetic retinopathy, vein occlusion, detachment, and vitreomacular interface disease. It addresses classification, epidemiology, treatment, management, and multimodal imaging for diagnosis.

This course will cover the causes of neurotrophic keratitis (NK) and how to identify and diagnose it, especially in its early stages. Treatments for NK and the importance of early intervention will also be discussed.

This lecture will dive into the role of Demodex Blepharitis in ocular surface disease including diagnosis and treatment, but recent research has shed light on the association between Demodex Blepharitis and meibomian gland disease (MGD). We’ll look at how MGD plays a role and review the findings of the Ersa study as it may apply to clinical practice.

This course will provide a comprehensive overview of the etiology and pathophysiology of neurotrophic keratitis. The presentation will cover key symptoms, signs, and differential diagnoses, with a focus on timely diagnosis and current management strategies.   

This course will review current options for managing keratoconus patients and challenges, risks, and complications for them. Educating on a new training can improve symptoms for patients, addressing needs without additional risk. The training can be educated, administered, and monitored in any optometric practice and can provide a new opportunity to improve patient symptoms while managing Keratoconus.

In this course, we will review how to select good patient candidates for custom soft lenses. Learn about live patient cases with an exciting presentation of grand rounds. 

This course introduces aesthetic considerations within the scope of optometric care, focusing on periocular and facial changes associated with aging, skin conditions relevant to ocular health, and patient-centered cosmetic concerns. The course will also review clinical tools and technologies used to evaluate and address these concerns, while remaining within the medical and ethical guidelines of optometric practice.

This course will cover patient populations at high risk for neurotrophic keratitis, recommend testing procedures to help with diagnosis and help formulate treatment plans to improve outcomes.

This course will highlight some of the pain points with custom soft lenses, and the solutions that currently exist. We will discuss the benefits of custom soft lenses as well.

This course provides a comprehensive overview of Dry Eye Disease (DED), including its multifactorial etiology, underlying pathophysiology, and current diagnostic and classification models. Attendees will gain insight into risk factors, diagnostic tools, and evidence-based treatment options for evaporative and aqueous-deficient dry eye. Emphasis will be placed on integrating DED management into routine optometric practice.

This course will look at the paradigm shift from multiple medications, side effects and cost to how we can utilize treatments which put the control and compliance in the doctors hands and reduce non compliance and adherence.

This course explores the anatomy and physiology of the blink mechanism and its role in maintaining ocular surface health. Attendees will learn about blink patterns, blink completeness, and the impact of blink dysfunction on meibomian gland health and tear film stability. The session will also examine diagnostic methods for evaluating blink mechanics and highlight clinical approaches to managing patients with blink-related disorders.

CXL has been approved in the U.S. for nearly a decade now. Dr. Lee will share the most memorable clinical lessons on CXL that has shaped his own clinical practice today, including the significance of FDA-approved CXL, how has it impacted patient quality-of-life (QoL) and reshaped clinical management, how to determine progression for treatment, can older patients progress, can patient younger than 14 be treated and his personal experience of retreating patients who continued to progress after investigational CXL treatments.

Glaucoma is like a large puzzle.  There are a lot of pieces of the puzzle that need to be put together to arrive at an accurate diagnosis.  This course will cover the data surrounding one of those pieces, corneal hysteresis, and its role in the diagnosis, management, and treatment of glaucoma.

This course will discuss the effects of lid disease, particularly demodex blepharitis, and its effect on contact lens wear. Ocular surface disorders can contribute to contact lens dropout, but how much of that is due to lid disorders and blepharitis. Focus will be placed on the nuances of demodex blepharitis, patient communication, and timely treatment and maintenance for contact lens success.

The use of laser energy, specifically laser peripheral iridotomy (LPI) and Selective Laser Trabeculoplasty (SLT), has been utilized in various forms of glaucoma for decades. This interactive 1 hour lecture will review and update clinical evidence and literature regarding laser peripheral iridotomy for narrow angle glaucoma and SLT for open angle glaucoma.

This presentation explores the sustained psychosocial and functional impact of vision rehabilitation in keratoconus patients. It extends upon previous work on psychological responses post-correction, examining neuroadaptive changes, health-related quality of life (HRQoL), and long-term patient satisfaction. This presentation also reviews emerging clinical frameworks for holistic keratoconus care.

The “medication first” era in glaucoma care is ending. This presentation reviews early-line interventional techniques, key new studies on MIGS, tube shunts, and trabeculectomy, and explores emerging advances in genetic testing and AI for diagnosis, management, and patient education.

Master slit lamp techniques and imaging to elevate anterior segment care for cataract and refractive patients. Enhance diagnostic confidence, streamline referrals, and optimize outcomes with modern tools like ZEISS imaging systems and advanced lenses.

This course provides a comprehensive overview of glaucoma medications, including their mechanisms of action, classifications, efficacy, side effects, and patient-specific considerations, with a focus on individualized treatment planning and shared decision-making to optimize patient outcomes.

Dry eye is a complex condition with diverse causes and treatment options. This lecture will cover modern diagnostic tools and therapies for ocular surface disease, using case examples to highlight practical approaches. Topics include medications, amniotic membranes, IPL, radiofrequency, photobiomodulation, and meibomian gland treatments.

This course will dig into first principles and physiological understanding of glaucoma in order to best understand and apply current management strategies including medication, SLT, sustained release options, and surgical procedures. Advances in understanding of pathophysiology, genetics, and the goal of development of disease-modifying therapies are highlighted.

Learn from scleral lens experts on 2025 advancements in scleral lenses. We will discuss the newest lens designs, optics, and more. There will be a patient demonstration as well as panel discussions from some of the leaders in the scleral lens field.

If you see even one collarette, treat it. Many practitioners hesitate, unsure of when to treat Demodex blepharitis. Early intervention is crucial, just as in other medical conditions. Don’t wait for the patient’s next visit—address the problem now.

This course will cover the unique challenges of evaluating and managing pediatric keratoconus, including in patients with developmental delay.

Ready to rethink presbyopia and unlock a powerful new revenue stream? This course will show you how to integrate therapeutic drops, enhance patient education, and build a presbyopia-focused care model that boosts revenue and elevates your practice. Learn actionable strategies to attract new patients, increase RPP, and streamline your workflow. Don’t get left behind—lead the next era of presbyopia care.

This course will review ocular surface disease, covering its definition, risk factors, and diagnosis. It will focus on blepharitis (including Demodex), chalazion, and hordeolum, with emphasis on modern in-office treatments (MBE, Thermal Expression, IPL, Amniotic Membranes) and updated pharmaceutical options (immunomodulators, new FDA-approved therapies, and pipeline drugs). Management strategies for glaucoma patients with blepharitis will also be discussed, with patient cases included if time permits.

This course covers scleral contact lens fitting and strategies to grow a scleral lens practice. Topics include research insights, patient recruitment, workflow optimization, fitting techniques, technology use, and troubleshooting common issues—illustrated with real patient cases to enhance clinical skills.